PPIDT00233
Drug Information
| Name | Buserelin |
|---|---|
| Sequence | Not Available |
| DrugBank_ID | DB06719 |
| Type | biotech |
| Indication | Buserelin may be used in the treatment of hormone-responsive cancers such as prostate cancer or breast cancer, estrogen-dependent conditions (such as endometriosis or uterine fibroids), and in assisted reproduction. |
Dosage Forms
| Form | Route | Strength |
|---|---|---|
| Spray | Nasal |
0.15 mg
|
| Implant | Parenteral |
6.3 MG
|
| Implant | Parenteral |
9.45 MG
|
| Injection, solution | — |
1 MG/ML
|
| Solution | Nasal |
100 mcg / act
|
| Solution | Subcutaneous |
1 mg / mL
|
| Spray | Nasal |
0.1 MG
|
| Injection | Parenteral |
1 mg/ml
|
| Implant; injection | Subcutaneous |
9.9 mg
|
| Implant | Subcutaneous |
6.3 mg
|
| Implant | Subcutaneous |
9.45 mg
|
| Implant | Parenteral |
9.450 mg
|
| Liquid | Subcutaneous |
1 mg / mL
|
| Injection | Subcutaneous |
1 mg/ml
|
| Spray | Nasal |
1 mg / mL
|
| Liquid | Nasal |
1 mg / mL
|
Target Information
| Role | Uniprot_ID | Gene_Name | Entity_Name | Organism | Actions | Internal link |
|---|---|---|---|---|---|---|
| target | P22888 | LHCGR | Lutropin-choriogonadotropic hormone receptor | Homo sapiens | unknown | Link |
| target | P30968 | GNRHR | Gonadotropin-releasing hormone receptor | Homo sapiens | unknown | Link |
| enzyme | P11511 | CYP19A1 | Aromatase | Homo sapiens | inducer | Link |